Friday 6 November 2026 Export IDXX’s income statement to Excel — free account

IDEXX Laboratories, Inc.

IDXX Healthcare Diagnostics & Research

IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024.

Revenue: +9.86%
EPS: +17.3%
Free cash flow: +17.6%
Total debt: −28.6%

Quarter to September 2026, against a year earlier

677.66 6.95 +1.04%

Follow IDXX

Alert me

Market cap: $52.8B
P/E: 44.8×
Fwd P/E: 37.3×
Dividend yield: —
F-score: 8/9
Altman Z: 24.09
Beneish M: −2.50
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

IDEXX Laboratories, Inc. 10-K filed Feb 21, 2025

Fiscal year 2024 · Period ended Dec 31, 2024 · Filed Feb 21, 2025 · accepted 8:28 AM ET · Document on sec.gov · Filing index

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 1, Business: no comparison — no earlier filing on file